Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study

被引:53
|
作者
Winter, Yaroslav [1 ]
von Campenhausen, Sonja [2 ]
Gasser, Julia [3 ]
Seppi, Klaus [3 ]
Reese, Jens-P. [1 ]
Pfeiffer, Karl-P. [4 ]
Botzel, Kai [2 ]
Oertel, Wolfgang H. [1 ]
Dodel, Richard [1 ]
Poewe, Werner [3 ]
机构
[1] Univ Marburg, Dept Neurol, D-35039 Marburg, Germany
[2] Univ Munich, Dept Neurol, D-8000 Munich, Germany
[3] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria
[4] Innsbruck Med Univ, Dept Med Stat Informat & Hlth Econ, Innsbruck, Austria
关键词
Parkinson's disease; Quality of life; EQ-5D; Austria; PREDICTORS; DISORDERS; IMPACT; SF-36; COSTS; EQ-5D;
D O I
10.1007/s00415-009-5389-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is associated with a reduction of health-related quality of life (HrQoL). Demographic and clinical determinants of HrQoL in PD have been previously investigated, but less is known about its social determinants. Data on HrQoL in Austrian patients with PD are not available. The objective of this cross-sectional survey was to evaluate HrQoL of Austrian patients with PD and to provide a comprehensive analysis of its social and clinical determinants. Outpatients (n = 100) with idiopathic PD were recruited in the Department of Neurology of the University Innsbruck. Clinical status was estimated using the Unified Parkison's Disease Rating Scale (UPDRS). HrQoL was evaluated using a generic instrument, the EuroQol (EQ5D and EQ-VAS). Independent determinants of HrQoL were assessed in multivariate regression analysis. The proportion of PD patients with moderate or severe problems in at least one dimension of the EQ5D was significantly higher than in the general population (90.1 vs. 35.1%, P < 0.001). The mean EQ-VAS score in PD was lower than in the general population (48.9 +/- A 19.6 vs. 77.0 +/- A 20.8, P < 0.001). Social support (number of household members) was identified as an independent social determinant of HrQoL. Demographic and clinical determinants were age, depression, UPDRS and motor fluctuations. The analysis of determinants of HrQoL showed that a greater attention should be paid to social support and home care. Our data on HrQoL in PD should be considered in the development of new health care programs.
引用
收藏
页码:638 / 645
页数:8
相关论文
共 50 条
  • [1] Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study
    Yaroslav Winter
    Sonja von Campenhausen
    Julia Gasser
    Klaus Seppi
    Jens-P. Reese
    Karl-P. Pfeiffer
    Kai Bötzel
    Wolfgang H. Oertel
    Richard Dodel
    Werner Poewe
    [J]. Journal of Neurology, 2010, 257 : 638 - 645
  • [2] Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study
    Winter, Yaroslav
    von Campenhausen, Sonja
    Popov, Georgy
    Reese, Jens P.
    Balzer-Geldsetzer, Monika
    Kukshina, Anastasia
    Zhukova, Tatyana V.
    Bertschi, Natalia
    Boetzel, Kai
    Gusev, Eugene
    Oertel, Wolfgang H.
    Dodel, Richard
    Guekht, Alla
    [J]. PARKINSONISM & RELATED DISORDERS, 2010, 16 (04) : 243 - 248
  • [3] Determinants of the quality of life in Parkinson's disease: Results of a cohort study from Southwest China
    Wu, Ying
    Guo, Xiao Yan
    Wei, Qian Qian
    Song, Wei
    Chen, Ke
    Cao, Bei
    Ou, Ru Wei
    Zhao, Bi
    Shang, Hui Fang
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) : 144 - 149
  • [4] Determinants of quality of life in a large, online cohort of patients with Parkinson's disease
    Bock, M.
    Brown, E.
    Tanner, C.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S558 - S558
  • [5] Determinants of quality of life in a large, online cohort of individuals with Parkinson's disease
    Bock, Meredith
    Brown, Ethan
    Zhang, Li
    Tanner, Caroline
    [J]. NEUROLOGY, 2021, 96 (15)
  • [6] The determinants of quality of life in Parkinson's disease
    Schrag, A
    [J]. MOVEMENT DISORDERS, 2002, 17 : S12 - S12
  • [7] Determinants of quality of life in Parkinson's disease: a perspective of novel clinical subtypes
    Fan, Yun
    Zhang, Mengwei
    Liang, Xiaoniu
    Shen, Bo
    Xu, Zhiheng
    Li, Shiyu
    Hu, Tianyu
    Wu, Bin
    Zhao, Jue
    Sun, Yimin
    Liu, Fengtao
    Tang, Yilin
    Wang, Jian
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (11): : 2174 - 2183
  • [8] Health-related quality of life and its determinants in Parkinson's disease: Results of an Italian cohort study
    Winter, Yaroslav
    von Campenhauseri, Sonja
    Arend, Martin
    Longo, Katia
    Boetzel, Kai
    Eggert, Karla
    Oertel, Wolfgang H.
    Dodel, Richard
    Barone, Paolo
    [J]. PARKINSONISM & RELATED DISORDERS, 2011, 17 (04) : 265 - 269
  • [9] Determinants of quality of life in Parkinson disease
    Kertelge, L.
    Brueggemann, N.
    Schmidt, A.
    Tadic, V.
    Wisse, C.
    Drude, L.
    Schneider, S. A.
    van der Vegt, J.
    Siebner, H.
    Lohmann, K.
    Buhmann, C.
    Hagenah, J.
    Klein, C.
    Kasten, M.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S64 - S64
  • [10] Determinants and impact of alexithymia on quality of life in Parkinson's disease
    Alvarado-Bolanos, A.
    Cervantes-Arriaga, A.
    Zuazua-Vidal, L.
    Esquivel-Zapata, O.
    Alcocer-Salas, A.
    Rodriguez-Violante, M.
    [J]. NEUROLOGIA, 2023, 38 (05):